SLC7A5 expression supports cancer progression, mostly by supplying essential amino acids to cancer cells, resulting in the activation of the mammalian target of rapamycin (mTOR) pathway to promote tumor proliferation [22]. The gene discussed is MTOR; the disease is neoplasm.